Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Looking for participantsNCT07106827What this trial is testingGV20-0251 in Advanced or Refractory Solid TumorsWho this might be right forHCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more West China Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02259725What this trial is testingRegorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+6 more University of Southern California 3
Early research (Phase 1)Study completedNCT00005860What this trial is testingOxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Post-approval studies (Phase 4)Not Yet RecruitingNCT06485739What this trial is testingIrinotecan Liposomes for the Treatment of Neuroendocrine CarcinomaWho this might be right forNeuroendocrine Tumors First Affiliated Hospital Xi'an Jiaotong University 20
Testing effectiveness (Phase 2)Study completedNCT02307500What this trial is testingRegorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard TherapyWho this might be right forPancreas CancerOvarian CancerMelanoma+4 more Istituto Clinico Humanitas 82
Testing effectiveness (Phase 2)Study completedNCT04731467What this trial is testingCM24 in Combination with Nivolumab in Adults with Advanced Solid TumorsWho this might be right forSolid TumorNon Small Cell Lung CancerPancreatic Cancer+4 more Famewave Ltd. 79
Large-scale testing (Phase 3)Looking for participantsNCT05477576What this trial is testingStudy of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyWho this might be right forGEP-NETGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine Tumor Disease+4 more RayzeBio, Inc. 338
Early research (Phase 1)Study completedNCT02166255What this trial is testingAPN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Looking for participantsNCT04325425What this trial is testingChemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown PrimaryWho this might be right forNeuroendocrine Carcinoma Centre Hospitalier Universitaire Dijon 218
Early research (Phase 1)Active Not RecruitingNCT03833700What this trial is testingE7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)Who this might be right forSolid NeoplasmsColorectal NeoplasmsGastrointestinal Tumors Eisai Co., Ltd. 70
Early research (Phase 1)Study completedNCT02077933What this trial is testingStudy of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic TumorsWho this might be right forNeoplasmsBreast NeoplasmsKidney Neoplasms+1 more Novartis Pharmaceuticals 79
Testing effectiveness (Phase 2)Study completedNCT00017199What this trial is testingPS-341 in Treating Patients With Metastatic Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell Tumor Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Temporarily pausedNCT06202066What this trial is testingTemozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine CarcinomasWho this might be right forDigestive System Neuroendocrine NeoplasmLung Neuroendocrine NeoplasmMalignant Solid Neoplasm+1 more Roswell Park Cancer Institute 60
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Study completedNCT00363051What this trial is testingSafety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to ChemotherapyWho this might be right forIslet Cell CarcinomaNeuroendocrine CarcinomaNeuroendocrine Tumor+1 more Novartis Pharmaceuticals 160
Large-scale testing (Phase 3)Looking for participantsNCT03755739What this trial is testingTrans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid TumorsWho this might be right forHepatocarcinomaLung CancerMelanoma+7 more Second Affiliated Hospital of Guangzhou Medical University 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT07023731What this trial is testingEvaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationWho this might be right forKRAS G12D MutationAdvanced Solid Cancer Arvinas Inc. 76
Early research (Phase 1)Study completedNCT02498665What this trial is testingDSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesGlioblastoma Multiforme+6 more Sumitomo Pharma America, Inc. 24